✦ LIBER ✦

9152 POSTER Comparative Value of Various Chemotherapy Regimens in 1st-line Treatment of Adenocarcinoma of the Lung

✍ Scribed by Hoverman, J.R.; Sheth, S.R.; Clayton, M.; Neubauer, M.A.; Kolodziej, M.A.; Anderson, R.W.; Beveridge, R.

Book ID: 122713304
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72464-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of S-1 plus nedaplatin compared

Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy

✍ Tang, Yu; Wang, Wei; Teng, Xiu-Zhi; Shi, Lin 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 272 KB

HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMO

HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS RECEIVING CARE IN THE OUTPATIENT COMMUNITY SETTING

✍ JR Hoverman; G Pohl; SK Gruschkus; M Marciniak; M Forsyth; G Peltz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

6619 POSTER Efficacy of weekly docetaxel

6619 POSTER Efficacy of weekly docetaxel combined with platinum as 1st-line treatment in patients with advanced non-small cell lung cancer

✍ Lee, W.S.; Bae, B.J.; Ryoo, H.M.; Bae, S.H.; Lee, S.C.; Hyun, D.S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Relationship between the expression of E

Relationship between the expression of ERCC-1, survivin and both efficiency and prognosis of cisplatin contained first-line chemotherapy in advanced lung adenocarcinoma

✍ Xiaobing Chen; Suxia Luo; Ning Li; Yongping Song; Junjie Zen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 162 KB

Comparative cost-minimisation of oral an

Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system

✍ K. Le Lay; E. Myon; S. Hill; L. Riou-Franca; D. Scott; M. Sidhu; D. Dunlop; R. L 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 170 KB

Phase II randomized study of daily gefit

Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

✍ Yuh-Min Chen; Jacqueline Ming Liu; Teh-Ying Chou; Reury-Perng Perng; Chun-Ming T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract ## BACKGROUND. The objective of this study was to assess the efficacy of adding chronic, intermittent, low‐dose vinorelbine to gefitinib treatment for patients who had adenocarcinoma of the lung who failed ≥2 regimens of chemotherapy. ## METHODS. Patients were randomized into 2 arms: